316 results on '"Braggion C"'
Search Results
52. 284 The Quality of Life (QoL) after lung transplantation (LT) between omnipotence, denial and reality principle
53. 73 Impact of community-acquired MRSA and hospital-acquired MRSA on pulmonary function of CF patients
54. 121 Anti-Pseudomonas aeruginosa antibodies and microbiological outcome in not chronically infected patients
55. 57 Emergence of a Panton-Valentine leukocidin (PVL) positive MRSA strain in cystic fibrosis (CF) patients
56. 88 Use of MALDI-TOF-MS for identification of anaerobic bacteria in CF patients
57. 156 Chronic airway colonization by Aspergillus fumigatus (Af) in patients with cystic fibrosis (CF): Does it contribute to lung function decline?
58. 321 Anxiety and depression in transplant patients
59. 128 Pseudomonas aeruginosa infecting lung-transplanted cystic fibrosis patients: A longitudinal study
60. 289 Vitamin D deficiency in patients attending the Tuscan regional cystic fibrosis centre
61. 216 Periodic application of continuous positive airway pressure (pCPAP) as airway clearance technique during advanced lung disease in cystic fibrosis: Another clue?
62. WS21.6 11 years of newborn screening (NBS): the experience in Tuscany, Italy
63. 132 MRSA epidemiology: a different diffusion in Italian cystic fibrosis centres
64. 329 Paternity in men with cystic fibrosis: an observational study in Italy
65. 325 Sexuality in cystic fibrosis (CF) patients
66. WS12.5 Fathers with cystic fibrosis in Italy: Who are they? How are they doing?
67. 46 Delay in meconium emission: should it be considered a risk for cystic fibrosis?
68. 365 Expectations and needs of cystic fibrosis (CF) patients and the CF center's response
69. 196 FEV1 decline in cystic fibrosis (CF): much attention should be devoted to children and adolescents
70. 393* CPAP for atelectasis in bronchopulmonary aspergillosis
71. 392 Brave lung: non invasive ventilation (NIV) and pneumothorax
72. 165 Evaluation of antibody against Pseudomonas aeruginosa in intermittently infected cystic fibrosis patients
73. 360 Mothers' and fathers' depression: how much cystic fibrosis (CF) or other variables affect it
74. 225 Analysis of bacterial pathogens before and after lung transplantation in cystic fibrosis patients
75. 134* Molecular characterization of methicillin-resistant Staphylococcus aureus (MRSA) strains responsible for the first infection in cystic fibrosis patients
76. 362 Emotional condition in the family of child and adolescent cystic fibrosis (CF) patients
77. 13 The CFTR S737F(c.2210C>T) mutation: genotype/phenotype correlation in seven subjects
78. Case Report: Cystic Fibrosis, Lung Transplantation, and the Novel H1N1 Flu
79. Non invasive ventilation (NIV) and pregnancy
80. Chromogenic versus cetrimide-based media for Pseudomonas aeruginosa isolation
81. Epidemiology of first/new Pseudomonas aeruginosa infection in cystic fibrosis patients
82. Molecular characterization of MRSA involved in persistent lung infections in cystic fibrosis patients: emergence of epidemic clones
83. Anxiety and depression in CF patients' fathers and mothers
84. Multicenter prospective study about complications of totally implantable central venous access ports in Italian people with CF: preliminary results
85. Community-Acquired MRSA causes earlier infection than Hospital-Acquired MRSA in patients with cystic fibrosis
86. Emotional condition of adult with cystic fibrosis (CF): implication of illness or structure of personality?
87. Heart assessment during exercise can predict pulmonary hypertension (PH) in CF?
88. Characterization of SCC mec types involved in persistent MRSA infections in cystic fibrosis patients
89. The Costs of Treatment of Early and ChronicPseudomonas aeruginosaInfection in Cystic Fibrosis Patients
90. Parenteral Administration of Tobramycin for Pulmonary Exacerbations in Cystic Fibrosis Patients: Toxicity, Serum Levels and Efficacy
91. CLINICAL IMPACT OF TOBI® ON CYSTIC FIBROSIS PATIENTS WITH CHRONIC PSEUDOMONAS AERUGINOSA COLONISATION: RESULT OF A POST-MARKETING SURVEILLANCE
92. “ANGELA'S CASE”
93. PROLONGING THE DURATION OF PERIPHERAL VENOUS CATHETERS IN CYSTIC FIBROSIS PATIENTS. RANDOMIZED CONTROLLED STUDY ON THE EFFECT OF DIFFERENT CONCENTRATIONS OF ANTIBIOTICS IN NORMAL SALINE
94. PERSISTENCE OF ACHROMOBACTER XYLOSOXIDANS IN CF PATIENTS: RESULTS OF A MOLECULAR STUDY
95. What do CF patients and their parents tell about infection control?
96. Gram-negative multiresistant non-epidemic strain infection in CF patients
97. Is the 1-meter distance enough to prevent cross-infection in cystic fibrosis? Preliminary results of a prospective study
98. Cost analysis of treatment for Pseudomonas aeruginosa infection in cystic fibrosis patients
99. Evolution of antibiotic resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients: results from a longitudinal study
100. 71 Follow-up of P. aeruginosa eradication in CF patients by RAPD analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.